HUTCHMED (China) (HMDCF) EBT Margin Growth (1y) (2016 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) EBT Margin Growth (1y) (2016 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 1,045.00 |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | -16,571.00 |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | -153.00 |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | -571.00 |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | 553.00 |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | 4,709.00 |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 1,911.00 |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | -2,328.00 |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | -801,907.00 |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -2,029.00 |
| Mar 31, 2021 | -1,640.00 |
| Jun 30, 2020 | 12,430.00 |
| Mar 31, 2020 | -12,765.00 |
| Dec 31, 2019 | -11,553.00 |
| Sep 30, 2019 | -9,185.00 |
| Jun 30, 2019 | -35,547.00 |
| Mar 31, 2019 | 11,252.00 |
| Jun 30, 2016 | 593.00 |